The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-4-methyl-N-(3-methyl-1-oxo-1-(pyridin-4-ylamino)butan-2-yl)cyclohexanecarboxamide ID: ALA2431529
PubChem CID: 40516541
Max Phase: Preclinical
Molecular Formula: C18H27N3O2
Molecular Weight: 317.43
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CC1CCC(C(=O)N[C@H](C(=O)Nc2ccncc2)C(C)C)CC1
Standard InChI: InChI=1S/C18H27N3O2/c1-12(2)16(18(23)20-15-8-10-19-11-9-15)21-17(22)14-6-4-13(3)5-7-14/h8-14,16H,4-7H2,1-3H3,(H,21,22)(H,19,20,23)/t13?,14?,16-/m0/s1
Standard InChI Key: XFOOPEAQNDHLSW-XUJLQICISA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
10.0814 -8.6354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6374 -10.6754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6638 -9.4617 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9508 -9.8728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2395 -9.4677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9536 -10.6993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6363 -9.8536 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9239 -9.4434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0846 -9.4563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2172 -9.8566 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3757 -9.8674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5318 -9.8764 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5053 -9.4510 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9261 -11.0872 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5306 -10.6997 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.3519 -11.0880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7965 -9.8620 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3788 -10.6884 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.2182 -10.6775 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5022 -8.6300 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2413 -11.1126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7876 -8.2241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3722 -8.2295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10 19 1 0
9 1 1 6
15 21 1 0
9 17 1 0
6 4 1 0
12 15 2 0
3 11 1 0
4 3 1 0
19 14 1 0
21 6 2 0
2 16 1 0
5 12 1 0
11 18 2 0
13 20 2 0
4 5 2 0
13 10 1 0
17 13 1 0
7 8 1 0
10 8 1 0
2 7 1 0
11 9 1 0
14 2 1 0
1 22 1 0
1 23 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 317.43Molecular Weight (Monoisotopic): 317.2103AlogP: 2.99#Rotatable Bonds: 5Polar Surface Area: 71.09Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.40CX Basic pKa: 5.63CX LogP: 2.74CX LogD: 2.74Aromatic Rings: 1Heavy Atoms: 23QED Weighted: 0.88Np Likeness Score: -1.22
References 1. Choi JY, Calvet CM, Gunatilleke SS, Ruiz C, Cameron MD, McKerrow JH, Podust LM, Roush WR.. (2013) Rational development of 4-aminopyridyl-based inhibitors targeting Trypanosoma cruzi CYP51 as anti-chagas agents., 56 (19): [PMID:24079662 ] [10.1021/jm401067s ]